Azithromycin for patients with frequent COPD exacerbations

Affiliations

¹ Counties Manukau District Health Board, Department of Respiratory Medicine, Middlemore Hospital, Otahuhu, Auckland 2025, New Zealand. Electronic address: conroy.wong@middlemore.co.nz.
² McGill University, Department of Respiratory Medicine, Montreal Chest Institute, Montreal, Canada.

Comment

Conroy Wong et al. Lancet Respir Med. 2014 May.

. 2014 May;2(5):340-1.

doi: 10.1016/S2213-2600(14)70087-6. Epub 2014 Apr 15.

¹ Counties Manukau District Health Board, Department of Respiratory Medicine, Middlemore Hospital, Otahuhu, Auckland 2025, New Zealand. Electronic address: conroy.wong@middlemore.co.nz.
² McGill University, Department of Respiratory Medicine, Montreal Chest Institute, Montreal, Canada.

No abstract available

Comment on

Azithromycin maintenance treatment in patients with frequent exacerbations of chronic obstructive pulmonary disease (COLUMBUS): a randomised, double-blind, placebo-controlled trial.
Uzun S, Djamin RS, Kluytmans JA, Mulder PG, van't Veer NE, Ermens AA, Pelle AJ, Hoogsteden HC, Aerts JG, van der Eerden MM. Uzun S, et al. Lancet Respir Med. 2014 May;2(5):361-8. doi: 10.1016/S2213-2600(14)70019-0. Epub 2014 Apr 15. Lancet Respir Med. 2014. PMID: 24746000 Clinical Trial.